Risks stratification and benefits of PCI: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 30: | Line 30: | ||
{{Electrocardiography}} | {{Electrocardiography}} | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
Revision as of 15:45, 20 August 2012
| Cardiology Network |
 Discuss Risks stratification and benefits of PCI further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor(s)-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Xin Yang, MA(Cantab), MB BChir, MRCP(Lond)